Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce abdominal cramping, reduced appetite, abdominal pain, malnutrition, and/or liver disease associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease study.
Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.
By joining the GI studies, your child may receive:
- Compensation for study-related time
- Reimbursement for study-related travel
- Study-related care from local doctors
- Study medication at no cost
Health insurance is not required to take part.
Enrollment is limited so act quickly.
